You are using an unsupported browser. Please update your browser to the latest version on or before July 31, 2020.

Showing articles from Drug development tag

Global Genes LIVE!: Mapping Patient Inclusion in Drug Development

Are you in the early stages of learning how to engage in the drug development process as an organization or individual patient? Then join us to get a strong understanding of the drug discovery and preclinical development processes. We will discuss the lifecycle of traditional therapies and new trends in research and d…

What is Druggable New Therapeutic Targets in Rare Disease

Only a fraction of the more than 7,000 rare diseases identified have approved therapies available. Advances in DNA sequencing have led to the identification of the genetic cause of several rare diseases, which can potentially lead to a better understanding of the disease and development of targeted therapies. Hear fro…

Patients and Caregivers: Shaping Clinical Drug Development

Starting a clinical trial is no simple task. From developing a protocol to patient recruitment to U.S. Food and Drug Administration (FDA) submission, there are a wide array of complex and closely monitored processes along the way. Patient and community involvement help ensure study questions are relevant and that the …

scroll to top icon